Robert Toto, MD, reviews key takeaways from the 2021 Academy of Managed Care Pharmacy meeting regarding healthcare resource utilization for patients with chronic kidney disease (CKD).
July 28th 2021, 2:30pm
New research indicates an association between longer chronic kidney disease duration and taste dysfunction.
July 25th 2021, 6:20pm
About 4 in 10 patients with chronic kidney disease will have “early rapid decline,” a trajectory more likely if the patient also has diabetes.
July 20th 2021, 7:00pm
Inconsistent application and measure of the Kidney Disease Improving Global Outcomes definition of acute kidney injury (AKI) prompted this review, which used a measure of 75% agreement when defining consensus.
July 18th 2021, 12:00pm
This new study from Japan investigated possible relationships between tubular injury, COVID-19 severity, and inflammatory markers with development of acute kidney injury.
July 15th 2021, 10:21pm
The dialysis company faces a $100M fine for each of 2 antitrust counts.
July 15th 2021, 11:00am
Positive drug trial results suggest promising outcomes for adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
July 12th 2021, 4:05pm
Exome sequencing of patients with kidney disease and their families identified 17 different monogenetic causes of kidney disease.
July 10th 2021, 7:31pm
A new study says that treating iron deficiency therapy may improve outcomes in patients with chronic kidney disease, even if they don’t have anemia.
July 9th 2021, 6:00pm
Considerable evidence shows sodium-glucose co-transporter-2 inhibitors have cardioprotective benefits, but new research elucidates the ways in which the drugs can also have positive renal impacts.
July 2nd 2021, 2:20pm
The proposed changes to the payment model for end stage renal disease (ESRD) would make it the first payment model under the CMS Innovation Center to directly address health equity by incentivizing increased rates of home dialysis and kidney transplants.
